InvestorsHub Logo
Followers 32
Posts 5263
Boards Moderated 0
Alias Born 03/25/2013

Re: None

Tuesday, 06/04/2024 9:29:42 AM

Tuesday, June 04, 2024 9:29:42 AM

Post# of 430194
I don't see a PR from Amarin on losing the PBM, but if it's true they should probably delay any buy backs.

These PBM deals have solidified the US market share around 57 percent, so perhaps losing this deal caused Holy to leave or be pushed out.

I too would like to see this be the catalyst to an authorized generic in the US.

Either way, hard to spin Holt leaving as anything other than a big negative. He was hardly here long enough to make an impact.

I'm a bit rattled by the news to be honest, and hope Denner and his BOD can scratch our way back to $4-5 eventually.

Need to see progress in EU/ROW for sure and 2039 exclusivity sure helps there.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News